Ticker LaunchSPAC · Liquidated
Sagaliam Acquisition Corp
Business combination with Virogentics Inc. and Biogenysis, Inc.
Sagaliam Acquisition Corp is a blank-check company (SPAC) that raised $100M in its initial public offering on Dec 22, 2021, listing on Nasdaq Global Market. It did not complete a business combination and liquidated around Sep 15, 2023, returning the trust to public shareholders. EF Hutton led the IPO, with Benchmark. Mayer Brown advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Dec 22, 2021
- IPO size
- $100M
- IPO exchange
- Nasdaq Global Market
- Target
- Virogentics Inc. and Biogenysis, Inc.
- SPAC counsel (IPO)
- Mayer Brown
- Underwriters' counsel (IPO)
- Loeb & Loeb
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Dec 22, 2021
- All filings on EDGAR CIK 1855351
Other SPAC IPOs from 2021
- NorthView Acquisition CorpDec 22, 2021 · $165M
- Gardiner Healthcare Acquisitions Corp.Dec 22, 2021 · $75M
- Larkspur Health Acquisition Corp.Dec 22, 2021 · $75M
- AP Acquisition CorpDec 20, 2021 · $150M
- Revelstone Capital Acquisition Corp.Dec 20, 2021 · $150M
- Invest Acquisition Corporation (formerly Investcorp Europe Acquisition Corp I)Dec 17, 2021 · $300M